Try our Advanced Search for more refined results
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Ventker Henderson
- Faruqi & Faruqi
- Cohen Milstein
- McGuireWoods
- Kirkland & Ellis
- Wexler Boley
- Sperling & Slater
- Smith Segura
- Vanek Vickers
- Wilson Sonsini
- Girard Sharp
- Grabar Law
- Garwin Gerstein
- Kaufman & Canoles
- Williams & Connolly
- Berger Montague
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Miller Shah LLP
- Goldman Ismail
- Kenny Nachwalter
- Hartley LLP
- Motley Rice
- Hangley Aronchick
- Radice Law Firm
- Lockridge Grindal
- Fisher & Phillips
- Winston & Strawn
- McDermott Will & Emery
- Willcox & Savage
- Morgan Lewis
- Zelle LLP
- Marcus & Shapira
- Hilliard & Shadowen
- BoiesBattin
- Durrette Arkema
- Boies Schiller
- The Office of Craig C. Reilly
- O'Hagan Meyer
- Nussbaum Law Group
- Gibson Dunn
- DLA Piper
- Katten Muchin
- Crenshaw Ware
- Hagens Berman
- Kessler Topaz
- Gustafson Gluek
- Glasser & Glasser
- Wolcott Rivers
- Joseph Saveri Law Firm
- Furniss Davis
- Crowell & Moring
- Taus Cebulash
- Woods Rogers
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- CVS Health Corp.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Fraternal Order of Police
- The Kroger Co.
- H‑E‑B LP
- Wegmans Food Markets Inc.
- Glenmark Pharmaceuticals Ltd.
- Health Net Inc.
- H.D. Smith LLC
- Cencora Inc.
- Rite Aid Corp.
- Albertsons Cos. Inc.
- Mutual Drug
- Merck & Co. Inc.
- Humana Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- McKesson Corp.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- Zydus Pharmaceuticals Inc.
- Centene Corp.
- Giant Eagle Inc.
Sectors & Industries:
-
August 24, 2020
Zetia Buyers Granted Cert. Despite Small Class Size
A Virginia federal judge granted class certification Friday to Zetia direct buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market, rejecting attacks on the small size of the class and the companies representing them.
-
August 17, 2020
Zetia Buyers Win Recommendation For Class Cert.
A federal magistrate judge has recommended that a group of Zetia buyers be granted class certification in a dispute accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market.
-
July 07, 2020
Merck, Glenmark Implore Court To Reject Zetia Class Cert.
Merck and Glenmark Pharmaceuticals are trying to convince a Virginia federal court to smack down a magistrate's recommendation to certify a class of direct purchasers who have accused the duo of conspiring to keep a generic version of the cholesterol drug Zetia off the market.
-
May 06, 2020
Zetia Buyers Blast Merck's 'Unhinged' Bid To Eject Class Rep
A proposed class of drug buyers is coming out swinging after the second of two "desperate efforts" to unseat its lead plaintiff in a suit accusing Merck and Glenmark Pharmaceuticals of teaming up to keep a generic version of the cholesterol drug Zetia off the market.
-
March 09, 2020
Judge OKs Par's Settlement In Zetia Pay-For-Delay Case
A Virginia federal judge has given the final greenlight to a settlement that knocks Par Pharmaceutical out of a massive suit accusing Merck and Glenmark of plotting to hold off generic versions of Zetia and inflating the cholesterol drug's costs.
-
December 23, 2019
Zetia Buyers' Lose Antitrust Claims Against Merck, Glenmark
Drug wholesalers and retailers alleging Merck, Glenmark and Par Pharmaceuticals were part of a conspiracy to keep generic versions of cholesterol drug Zetia off the market can't sue Merck and Glenmark for overcharges they purportedly paid for Glenmark's generic, a Virginia federal judge ruled.
-
November 19, 2019
Direct Buyers Seek Cert. In Zetia Generic Delay Suit
Direct drug buyers accusing Merck and Glenmark of conspiring to keep a generic version of the cholesterol drug Zetia off the market have urged a Virginia federal judge to certify their class, saying the alleged conspiracy forced the class members to pay higher prices.
-
October 30, 2019
Zetia Generic Delay Was A Conspiracy, Court Told
A Virginia federal judge was wrong to recommend that drugmakers Merck and Glenmark be cleared of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market, direct drug buyers said Tuesday.
-
October 29, 2019
Retailers Fight To Keep 3-Way Zetia Conspiracy Claim In MDL
Kroger, Walgreens and a host of other retailers urged a Virginia federal judge Tuesday not to take up a magistrate's recommendation to clear Merck and Glenmark of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market.
-
October 16, 2019
Toss 3-Way Zetia Conspiracy Claim, Judge Says
A group of direct purchaser plaintiffs may find it harder to prove a pay-for-delay scheme over a generic version of Merck's Zetia after a Virginia federal judge recommended Tuesday that the drugmaker and generics company Glenmark be cleared of allegations of a three-way conspiracy with Glenmark's distributor, Par Pharmaceuticals.